PolyIC-Coated Prussian Blue Nanoparticles As a Dual-Mode HIV Latency Reversing Agent is a research paper published in Nanomedicine (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: AI117970, R01-AI124722, R33AI136102, T32 AI158105
NIAID NIH HHS
Grant: P30 AI117970
NIAID NIH HHS
Grant: R01 AI124722
NIAID NIH HHS
Grant: T32 AI158105
NIAID NIH HHS
Grant: R33 AI136102
National Institutes of Health
Grant: 3P30AI117970-10S4
District of Columbia Center for AIDS Research
National Institutes of Health
Grant: 4R33AI136102-03
Biomaterials-Enhanced NK Cells for Improved Elimination of the HIV Reservoir
National Institutes of Health
Grant: 1T32AI158105-01A1
Training in HIV Persistence, Co-morbidities and Therapeutics
National Institutes of Health
Grant: 7R01AI124722-02
Developing Pathogen Recognition Receptor Agonists as Latency Reversing Agents
FWCI
0.07
Citation Percentile
0.4%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
PolyIC-coated Prussian blue nanoparticles as a dual-mode HIV latency reversing agent - Supplementary dataset
PolyIC-coated Prussian blue nanoparticles as a dual-mode HIV latency reversing agent - Supplementary dataset